Back to Search
Start Over
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
- Source :
-
Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2021 Feb; Vol. 75 (2), pp. 57-62. Date of Electronic Publication: 2020 Dec 19. - Publication Year :
- 2021
-
Abstract
- Aim: Tipepidine, a synthetic, non-opioid expectorant, has been shown to improve depressive-like behavior in animal models of depression. In this study, we assessed the efficacy and tolerability of tipepidine combination therapy with citalopram in treatment of major depressive disorder (MDD).<br />Methods: In a randomized, double-blinded, placebo-controlled clinical trial, 62 patients with MDD were assigned into two parallel groups to receive citalopram (up to 40 mg/day) plus placebo or citalopram plus tipepidine (30 mg twice daily) for 6 weeks. Participants were assessed with the Hamilton Rating Scale for Depression (HAM-D) at baseline and Weeks 2, 4, and 6.<br />Results: Fifty-six patients completed the trial. The tipepidine group showed greater improvement in HAM-D scores from baseline to all three study time points (P = 0.048 for all). The remission and response-to-treatment rates were significantly higher in the tipepidine group (53.6% and 100%) compared to the placebo group (25.0% and 75%) at the study end-point (P = 0.029 and 0.005, respectively). The remission and response times in patients in the tipepidine group were also shorter compared with the placebo group (log-rank P = 0.020 and 0.004). There was no significant difference between the two groups in baseline parameters or frequency of side-effects.<br />Conclusion: Tipepidine combination therapy with citalopram can effectively improve symptoms of patients with MDD in a shorter period of treatment. However, further studies with larger sample sizes and longer follow-up treatment are needed to confirm our findings.<br /> (© 2020 The Authors Psychiatry and Clinical Neurosciences © 2020 Japanese Society of Psychiatry and Neurology.)
- Subjects :
- Adult
Citalopram administration & dosage
Depressive Disorder, Major
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Outcome Assessment, Health Care
Piperidines administration & dosage
Selective Serotonin Reuptake Inhibitors administration & dosage
Time Factors
Citalopram pharmacology
Piperidines pharmacology
Selective Serotonin Reuptake Inhibitors pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1440-1819
- Volume :
- 75
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Psychiatry and clinical neurosciences
- Publication Type :
- Academic Journal
- Accession number :
- 33247483
- Full Text :
- https://doi.org/10.1111/pcn.13180